Johnson & Johnson (NYSE:JNJ) said today it launched its Cerenovus brand, which combined its Pulsar Vascular and Neuravi acquisitions and its remaining Codman Neuro neurological portfolio. Cerenovus was launched at the European Society of Minimally Invasive Neurological Therapy’s 9th annual meeting, J&J said. Johnson & Johnson said that the Cerenovus product portfolio aims to help improve stroke care, with the number […]
Pulsar Vascular
Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz
Updated to clarify that J&J’s existing Codman Neuro neurovascular portfolio will also be included in the new Cerenovus business. Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions, as well as its existing Codman Neuro neurological portfolio, into a new neurovascular business dubbed Cerenovus. The […]
J&J’s Codman Neuro picks up Pulsar Vascular
Johnson & Johnson‘s (NYSE:JNJ) Codman Neuro said last week it picked up Pulsar Vascular, which produces the PulseRider device for treating brain aneurysms, for an undisclosed amount. The PulseRider is designed to shore up the blood vessels around wide-necked aneurysms at or near a bifurcation of the basilar tip or carotid terminus and facilitate the implantation of […]
Pulsar Vascular raises $9.5m for PulseRider aneurysm device
Pulsar Vascular, which makes the PulseRider device for treating brain aneurysms, said it raised nearly $9.5 million from 39 unnamed investors. The 1st sale in the equity, debt and options round happened July 27, San Jose, Calif.-based Pulsar Vascular said in a regulatory filing. The PulseRider device is designed to shore up the blood vessels around […]
